5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study (Q45777369)

15 December 2017

title

5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study (English)

1 reference

15 December 2017

1 reference

6

Guido Reifenberger

1 reference

15 December 2017

3

Jörg Felsberg

1 reference

15 December 2017

Marcel A Kamp

1

1 reference

15 December 2017

Philipp Grosser

2

1 reference

15 December 2017

Philipp J Slotty

4

1 reference

15 December 2017

Hans-Jakob Steiger

5

1 reference

15 December 2017

Michael Sabel

7

1 reference

15 December 2017

publication date

12 November 2011

1 reference

15 December 2017

published in

Acta Neurochirurgica

1 reference

15 December 2017

volume

154

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

223-8; discussion 228

1 reference

15 December 2017

https://scigraph.springernature.com/pub.10.1007/s00701-011-1200-5

exact match

0 references

cites work

Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

A pathology-based substrate for target definition in radiosurgery of brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Hypoxia signalling controls metabolic demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Raman spectroscopy of bladder tissue in the presence of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

5-Aminolaevulinic Acid (ALA) for the Fluorescence Detection of Bronchial Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

ALA and its clinical impact, from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

New incoherent autofluorescence/fluorescence system for early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Regulation of ferrochelatase gene expression by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

Photodynamic diagnosis of prostate cancer using 5-aminolevulinic acid--first clinical experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1200-5

10.1007/S00701-011-1200-5

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

0 references

1 reference

15 December 2017